These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33082247)

  • 1. Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948-955.
    Fu EL; van Diepen M
    Diabetes Care; 2020 Nov; 43(11):e190. PubMed ID: 33082247
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948-955.
    Kwon S; Kim CT; Lee JP
    Diabetes Care; 2020 Nov; 43(11):e191. PubMed ID: 33082248
    [No Abstract]   [Full Text] [Related]  

  • 3. [Metformin is also recommended in mild and moderate renal failure].
    Zechmann S
    Praxis (Bern 1994); 2015 Mar; 104(7):370-1. PubMed ID: 25804780
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metformin and kidney].
    Sessa C; Blanco J; Granata A; Fatuzzo P; Castellino P; Zanoli L
    G Ital Nefrol; 2016; 33(3):. PubMed ID: 27374392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes: Metformin and renal insufficiency-is 45, or even 30, the new 60?
    Bloomgarden Z
    Nat Rev Endocrinol; 2015 Dec; 11(12):693-4. PubMed ID: 26416220
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of Metformin Use in Diabetic Kidney Disease.
    Kawanami D; Takashi Y; Tanabe M
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing of metformin based on estimated GFR rather than serum creatinine expands the eligible population and is likely safe.
    Castelino RL; Peterson G
    Evid Based Med; 2016 Apr; 21(2):68. PubMed ID: 26786825
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diabetes treatment in patients with chronic kidney disease].
    Süfke S; Steinhoff J; Schütt M
    Dtsch Med Wochenschr; 2013 May; 138(21):1109-18; quiz 1119-22. PubMed ID: 23677506
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal status among patients using metformin in a primary care setting.
    Kennedy L; Herman WH;
    Diabetes Care; 2005 Apr; 28(4):922-4. PubMed ID: 15793196
    [No Abstract]   [Full Text] [Related]  

  • 10. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease.
    Kwon S; Kim YC; Park JY; Lee J; An JN; Kim CT; Oh S; Park S; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Diabetes Care; 2020 May; 43(5):948-955. PubMed ID: 32132005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoglycemics for the treatment of type 2 diabetes in patients with chronic kidney disease: a focus on new agents.
    Fang V; Wazny LD; Raymond CB
    CANNT J; 2012; 22(1):30-6; quiz 37-8. PubMed ID: 22558681
    [No Abstract]   [Full Text] [Related]  

  • 12. [How I treat ... with metformin a diabetic patient with moderate renal insufficiency].
    Scheen AJ
    Rev Med Liege; 2013 Apr; 68(4):190-5. PubMed ID: 23755710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comment on Xu et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 2015;38:1858-1867.
    Sonne DP; Knop FK
    Diabetes Care; 2015 Dec; 38(12):e215. PubMed ID: 26604291
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to Comment on Xu et al. Effects of Metformin on Metabolite Profiles and LDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 2015;38:1858-1867.
    Brandmaier S; Xu T; Illig T; Suhre K; Adamski J; Wang-Sattler R
    Diabetes Care; 2015 Dec; 38(12):e216-7. PubMed ID: 26604292
    [No Abstract]   [Full Text] [Related]  

  • 15. Discrepancies between the summary of characteristics and the recommended use of metformin in the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; López-Menchero R
    Nefrologia; 2012; 32(6):837-8; author reply 388-9. PubMed ID: 23169370
    [No Abstract]   [Full Text] [Related]  

  • 16. Antidiabetics in chronic kidney disease: new questions to new and classical drugs.
    Serra-Tarragón J
    Nefrologia; 2012; 32(6):835; author reply 835-7. PubMed ID: 23169369
    [No Abstract]   [Full Text] [Related]  

  • 17. Review: metformin: potential benefits and use in chronic kidney disease.
    Pilmore HL
    Nephrology (Carlton); 2010 Jun; 15(4):412-8. PubMed ID: 20609092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
    MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
    [No Abstract]   [Full Text] [Related]  

  • 19. Conference report: renal disease, metformin, and the adipocyte.
    Bloomgarden ZT
    Diabetes Care; 1996 Sep; 19(9):1038-41. PubMed ID: 8875112
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetic kidney disease in 2017: A new era in therapeutics for diabetic kidney disease.
    Wanner C
    Nat Rev Nephrol; 2018 Feb; 14(2):78-80. PubMed ID: 29307892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.